by HBOT News | Apr 19, 2016 | Clinical Trials, HBOT Research, Ischemic Heart Disease
Hyperbaric oxygen therapy (HBOT) is proposed as a possible in vivo angiogenic stimulator for
improving microvascular myocardial perfusion and anginal symptoms as assessed by myocardial
perfusion imaging and angina questionnaire in patients with chronic stable ischemic heart
disease, when no other means to relief symptoms and/or ischemia are available.
by HBOT News | Mar 23, 2016 | Diabetic Foot Ulcers
Abstract: We obtained costs and mortality data in two retrospective cohorts totaling 159 patients who have diabetes mellitus and onset of a diabetic foot ulcer (DFU). Data were collected from 2005 to 2013, with a follow-up period through September 30, 2014. A total of...
by HBOT News | Feb 19, 2016 | Clinical Trials, HBOT Research, Postoperative Analgesia
Purpose: This prospective, randomised, controlled, single-blind, multicentre study was
designed to investigate the effects of peripheral nerve block methods (applied using
unilateral spinal anaesthesia [USA] on elderly patients scheduled to undergo total knee
arthroplasty) on perioperative haemodynamic parameters and the postoperative analgesia
period.
Materials and Methods: Sixty patients in the American Society of Anesthesiologists (ASA)
Physical Status II-III group were randomly divided into two groups. Spinal anaesthesia was
performed in the USA group, in the lateral position through the intervertebral space, with 2
ml of hyperbaric bupivacaine (L4-L5 or L3-L4); 0.5% bupivacaine hydrochloride and 2%
lidocaine were combined for the psoas compartment-sciatic (PCS) group, and the mixture was
used for psoas compartment block (PCB) and sciatic nerve block. The haemodynamic parameters
were recorded every 5 minutes until the end of the preoperative and perioperative operation
periods and postoperative first analgesic application time.
by HBOT News | Feb 12, 2016 | Cancer
Abstract: Hyperbaric Oxygen Therapy (HBOT) is increasingly applied in different areas of medical practice. The oxy-hyperbarism effects are not well understood in cancer malignancy. One unique feature of cancer is the presence of hypoxic regions that are insensitive to...
by HBOT News | Feb 6, 2016 | Cancer
Abstract: To evaluate the efficacy of hyperbaric oxygen therapy (HBO) in the treatment of postradiation hematuria (PRH) and to identify the predictive factors for a successful outcome. We conducted a retrospective study and included all patients with PRH treated with...
